Hepatitis B: HB Surface Antibodies

Hepatitis B surface antibody (anti-HBs) is a marker of immunity to hepatitis B virus, which may develop following vaccination or recovery from past infection. The presence of anti-HBs is generally considered protective, with levels above 10 mIU/mL commonly regarded as indicative of adequate immunity.

The findings related to these particular clinical tests are a general guide and do not cover every possible scenario, this is because every patient is unique and these results only have true clinical significance when combined with the patient’s full medical history, a physical exam, and other diagnostic findings.

Phlebotomy service fee: £21.